High Performance Liquid Chromatographic Assay of Ciprofloxacin in Human Plasma using Fluorescence Detection

Abstract

Keywords

• -

References

1. Vance-Bryan K.; Guay D.R.P.; Rotschafr J.C. Clinical Pharmacokinetics of ciprofloxacin. Clin. Pharmacokinet. 19:434-461 (1990)
2. Tartaglione T.A.; Raffalovich A.C.; Poynor W.J.; Espinel-Ingroff “Pharmacokinetics and tolerance of ciprofloxacin after Antimicrob. Agents Chemother. 29:62-66 (1986) oral doses”.
3. Bergan T.; Engeset A.; Olszewski W.; Osytby N.; Solberg R., “Pharmacokinetics of ciprofloxacin in peripheral lymph and skin blisters”, Eur. J. Clin. Microb. 5:458-461(1986)
4. Jehl F, Gallion C,Debs J, Brogard JM, Monteil H, Minck R.High performance liquid chromatographic method for the determination of ciprofloxacin in biological fluids. J. Chromatogr. 339: 347-357 (1985)
5. Chamseddin C.; Jira T.H. Comparison of the behavior ciprofloxacin and moxifloxacin on various HPLC phases Pharmazie 66: 244-248 (2011)
6. Marika K.; Kimiko T.; Kotegawa T.; Nakamura .; Nakano S. Determination of ciprofloxacin in plasma and urine by HPLC wit ultraviolet detection. Clinical Chemistry 44 : 1251-1255 (1998)
7. Weber A.; Chaffin D.; Smith A.; Opheim KE. Quantitation of ciprofloxacin in body fluids by high-pressure liquid chromatography. Antimicrob Agents Chemother. 27:531–534 (1985) Vallée
8. Determination of ciprofloxacin in biological samples by reversed-phase high performance liquid chromatography. Ther Drug Monit. 8:340– 345 (1986)

9. Omari D.M. ; Johary D. ; Salem I.I., Najib N.; Eposito S.; Galante D.; Barba D.; D’errico G.; Mazzone A. Ciprofloxacin concentrations in human fluids and tissues following a single oral dose. J. Clin. Pharmacol. Res. 7:181-186 (1987)
10. Groeneveld A.J.; Brouwers J.R. Quantitative determination norfloxacin and pefloxacin in serum by high pressure liquid chromatography. Pharm Weekbl Sci. 21;8(1):79–84 (1986) ciprofloxacin,
11. Borner K.; Hoffken G.; Lode H.; Koeppe P.; Prinzing C. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. Eur. J. Clin. Microb. 5:179-186 (1986)
12. Davis R.L.; Koup J.R.; Williams-Warrent J.; Weber A.; Heggen L. Pharmacokinetics of ciprofloxacin in optic fibrosis. Antimicrob. Agents Chemother. 31:915-919 (1987)
13. Drusano GL, Standiford HC, Plaisance K, Forrest A, Leslie J. Absolute oral bioavailability of ciprofloxacin. Antimicrob. Agents Chemother. 30:444-446 (1986)
14. Lovdahl M, Steury J, Russlie H, Canafax DM. Determination of ciprofloxacin levels in chinchilla middle ear effusion and plasma by high performance fluorescence detection. J Chromatogr 617:329- 333 (1993) with
15. Hoffken G.; Lode H.; Prinzing C.; Borner K.; Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob. Agents Chemother. 27:375-379 (1985)
16. Wollf M.; Bourton L.; Singlas E.; Clair B.; Decazes J.M.; Regnier B. Penetration of ciprofloxacin into cerebrospinal fluid of patients with baterial meningitis. Antimicrob. Agents Chemother. 31:899-902 (1987)
17. Lacey L.F.; Keene O.N.; Duquesnoy C.; Bye A. Evaluation of different indirect measures of rate of pharmacokinetics. J. Pharm.Sci, 83:212-215 (1994) in comparative Khan M.K., Khan and bioequivalence ciprofloxacin in healthy male subjects. Pakistan journal of Pharmaceutical Sciences 22:1- 7(2009). of
18. Sallam A.A. Bioequivalence of two oral extended release formulations of ciprofloxacin tablets in healthymale volunteers under fed and fasting conditions. Journal of Bioequivalence and Bioavailability 3: 38-42(2011).